Growth in the global centesis catheters market can be attributed to factors such as the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases.
The Centesis
Catheters Market is projected to reach USD 633 million by
2025 from USD 426 million in 2019, at a CAGR of 6.8%.
Download PDF
Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=254850580
Market Segmentation:
Small-bore centesis
catheters segment accounted for the largest share of the centesis catheters
market, by type, in 2018
Based on type, the centesis catheters market is segmented into
small-bore and large-bore centesis catheters. The small-bore centesis catheters
segment accounted for the largest share of this market in 2018. This can be
attributed to the wide availability of small-bore centesis catheters, growing
number of target procedures that require small-bore centesis catheters,
increasing evidence of the efficacy and safety of small-bore centesis catheters
over large-bore centesis catheters, and their higher adoption in diagnostic
centesis procedures.
Paracentesis procedures segment accounted for the largest share
of the centesis catheters market, by procedure, in 2018
Based on procedure, the centesis catheters market is segmented
into paracentesis, thoracentesis, arthrocentesis, amniocentesis, and other
procedures. The paracentesis segment accounted for the largest share of this
market in 2018. The rising incidence of target conditions such as
gastrointestinal malignancies, liver cirrhosis, cystic fibrosis, intestinal
tuberculosis, chronic liver failure, formation of cysts in the peritoneal
cavity, and serious forms of hepatitis is expected to drive the growth of this
market segment in the coming years.
Hospitals were the
largest end users of centesis catheters in 2018
Based on end user, the global centesis catheters market has been
segmented into hospitals, ambulatory surgical centers, and other end users. The
hospitals segment accounted for the largest share of the market in 2018. This
is because the majority of centesis procedures are performed in hospitals owing
to the risks involved in these procedures and the higher patient preference for
hospital-based care for target disease conditions, such as gastrointestinal
malignancies, liver cirrhosis, cystic fibrosis, intestinal tuberculosis,
chronic liver failure, peritonitis, and pleural effusion.
Regional Analysis: -
Asia Pacific is
the fastest-growing regional market for centesis catheters
The Asia
Pacific market is estimated to grow at the highest CAGR
during the forecast period. This can be attributed to the presence of a large
patient pool, increasing incidence and prevalence of target diseases, improving
healthcare infrastructure in Asian countries, and the favorable government
initiatives for improving access to healthcare.
Recent Developments
·
In 2019, Galt Medical Corp (US) acquired Arrotek
Medical Limited (Ireland) that expanded the former’s minimally invasive devices
portfolio.
·
In 2019, Merit Medical (US) launched the ReSolve
Mini Locking Drainage Catheter with a 42% smaller pigtail design (as compared
to the other ReSolve Mini drainage catheters offered by the company).
·
In 2017, Teleflex Incorporated (US) acquired
Vascular Solutions, Inc. (US).
·
In 2017, Cardinal Health (US) acquired the Patient
Care, Deep Vein Thrombosis, and Nutrient Insufficiency business lines from
Medtronic, plc (Ireland).
Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=254850580
Key players:
The key players operating in the global centesis catheters
market are AngioDynamics, Inc. (US), ARGON MEDICAL (US), Avanos Medical Devices
(US), Axiom Medical, Inc. (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and
Company (US), Blue Neem Medical Devices Pvt. Ltd. (India), Boston Scientific
Corporation (US), Canadian Hospital Specialties Ltd. (Canada), Cardinal Health (US),
Cook Medical (US), Galt Medical Corp. (US), Guangzhou Leadgem Medical Device
Co., Ltd. (China),
KM Medical (US), Medical Components, Inc. (US), Medtronic (Ireland),
Merit Medical Systems (US), Mermaid Medical A/S (Denmark), MoFlo Medical Technology
Co., Ltd. (China),
Neuromedex GmbH (Germany),
Ningbo Honde Medical Instruments Co., Ltd. (China), PFM Medical, Inc. (US),
Polymedicure (India),
REDAX (Italy),
Rocket Medical plc. (UK), Romsons (India), Smiths Medical (US),
Teleflex Incorporated (US), UreSil, LLC (US), and Utah Medical Products, Inc.
(US).
No comments:
Post a Comment